LOGC (LOGC) Stock Price & Analysis
LOGC (LOGC) rose 0.78% to USD 12.95 as of September 8, 2026 at 06:56 UTC, according to Nexqual real-time market data.
LOGC last closed at USD 12.95; the session ranged USD 12.77–12.95 on volume of 13,161 shares. Market capitalization is —, with a 52-week range of USD 7.05–13.25 (OQB). Source: Nexqual, September 8, 2026 at 06:56 UTC.
Key Statistics (as of September 8, 2026 at 06:56 UTC)
| Price | USD 12.95 |
|---|---|
| Change | ▲ 0.78% (up) |
| Previous Close | USD 12.95 |
| Open | USD 12.95 |
| Day Range | USD 12.77 – 12.95 |
| 52-Week Range | USD 7.05 – 13.25 |
| Volume | 13,161 shares |
| Market Cap | — |
| Exchange | OQB |
Technical Analysis (LOGC)
Nexqual's technical model rates LOGC "BUY" based on 5 bullish and 2 bearish signals across 128 daily candles, as of September 8, 2026 at 06:56 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 84.24 (overbought) |
| vs SMA50 | Above (USD 10.3) |
| MACD | 0.82 (positive) |
From LOGC's Latest SEC 10-K Filing (filed 2026-03-05)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| KLDO | Kaleido Biosciences, Inc. | USD 0 | ▲ 0% |
| DTIL | Precision BioSciences, Inc. | USD 7.47 | ▲ 0.27% |
| GOSS | Gossamer Bio, Inc. | USD 0.18 | ▲ 1.33% |
| ALEC | Alector, Inc. | USD 2.46 | ▼ 9.56% |
| SPRO | Spero Therapeutics, Inc. | USD 1.21 | ▼ 0.82% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 06:56 UTC. This page is informational and not investment advice.